Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-27T17:54:30.824Z Has data issue: false hasContentIssue false

Chapter 11 - Ovulation Induction in Polycystic Ovary Syndrome

Published online by Cambridge University Press:  13 May 2022

By
Evert J. P. van Santbrink
Edited by
Gabor T. Kovacs ,
Bart Fauser  and
Richard S. Legro
Gabor T. Kovacs
Affiliation:
Monash University, Melbourne, Australia
Bart Fauser
Affiliation:
University Medical Center, Utrecht, Netherlands
Richard S. Legro
Affiliation:
Penn State Medical Center, Hershey, PA, USA
Get access

Summary

Chronic anovulation is a very common disorder in polycystic ovary syndrome (PCOS) patients wishing to conceive. In these patients, ovulation induction resulting in restoration of a regular menstrual cycle with monofollicular ovulation may normalize the probability of pregnancy. This may be achieved either by increasing the follicle-stimulating hormone (FSH) serum concentration or by improving the endocrine ovarian milieu resulting in enhanced FSH responsiveness of the ovaries. Later on, this favorable endocrine milieu may also benefit implantation, embryo development and reduce risks in pregnancy for mother and child. A combination of both strategies could be used to individualize treatment in a patient-tailored way: for every patient an optimal effective treatment plan based on specific individual characteristics. Although there has been a tendency to ultimately skip ovulation induction and start in vitro fertilization (IVF) immediately because this would result in better pregnancy chances, this choice neglects the significant risks and physical burden of IVF treatment and significant higher costs. Ovulation induction in PCOS patients, as discussed in this chapter, is a very successful treatment option with a cumulative single live birth of greater than 70% during a 24-month follow-up period.

Keywords

ovulation inductionclomiphene citrateletrozolemetforminfollicle-stimulating hormone (FSH)gonadotropinsaromatase inhibitorsinsulin sensitizerscomplicationspregnancy
Type
Chapter
Information
Polycystic Ovary Syndrome , pp. 102 - 109
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

The Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19(1): 41–47.Google Scholar
Mitwally, M. F., Biljan, M. M. and Casper, R. F. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005; 192(2): 381–386.CrossRefGoogle ScholarPubMed
Tatsumi, T., Jwa, S. C., Kuwahara, A. et al. No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in ART. Hum Reprod 2017; 32(1): 125–132.Google Scholar
Franik, S., Eltrop, S. M., Kremer, J. A. M. et al. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018; 5(5): CD010287.Google ScholarPubMed
Caspar, R. F. and Mitwally, M. F. M. Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 2006; 91(3): 760–771.Google Scholar
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E. and Self, S. G. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331(12): 771–776.CrossRefGoogle Scholar
Homburg, R. Clomiphene citrate – end of an era? A mini-review. Hum Reprod 2005; 20(8): 2043–2051.CrossRefGoogle Scholar
Coffler, M. S., Patel, K., Dahan, M. H. et al. Enhanced granulosa cell responsiveness to follicle-stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone. J Clin Endocrinol Metab 2003; 88(12): 5624–5631.CrossRefGoogle ScholarPubMed
Morley, L. C., Tang, T., Yasmin, E. et al. Insulin-sensitizing drugs (metformin, rosiglitazone, pioglitazone, D-inositol) for women with PCOS, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2017; 11(11): CD003053.Google Scholar
Rausch, M. E., Legro, R .S., Barnhart, H. X. et al. Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94(9): 3458–3466.Google Scholar
Glueck, C. J., Goldenberg, N., Pranikoff, J. et al. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004; 19(6): 1323–1330.CrossRefGoogle ScholarPubMed
Weiss, N. S., Kostova, E., Nahuis, M. et al. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2019; 1(1): CD010290.Google Scholar
van Santbrink, E. J. and Fauser, B. C. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: Prospective, randomized comparison between low dose step-up and step-down dose regimens. J Clin Endocrinol Metab 1997; 82(11): 3597–3602.Google ScholarPubMed
Christin-Maitre, S. and Hugues, J. N. Recombinant FSH Study Group: A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod 2003; 18(8): 1626–1631.Google Scholar
van Santbrink, E. J., Eijkemans, M. J., Laven, J. S. and Fauser, B. C. Patient-tailored conventional ovulation induction algorithms in anovulatory infertility. Trends Endocrinol Metab 2005; 16(8): 381–389.CrossRefGoogle ScholarPubMed
Balen, A. H., Morley, L. C., Misso, M. et al. The management of anovulatory infertility in women with polycystic ovary syndrome: An analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 2016; 22(6): 687–708.Google Scholar
Mulders, A. G., Eijkemans, M. J., Imani, B. et al. Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod BioMed Online 2003; 7(2): 170–178.Google Scholar
Teede, H. J., Misso, M. L., Costello, M. F. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110(3): 364–379.Google Scholar
Eijkemans, M. J., Imani, B., Mulders, A. G., Habbema, J. D. and Fauser, B. C. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod 2003; 18(11): 2357–2362.Google Scholar
Bordewijk, E. M., Nahuis, M., Costello, M. F. et al. Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev 2017; 1(1): CD009090.Google ScholarPubMed
Amer, S. A., Li, T. C., Ledger, W. L. Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: Predictors of success. Hum Reprod 2004; 19(8): 1719–1724.Google Scholar
Goldman, R. H., Batsis, M., Petrozza, J. C. and Souter, I. Patient-specific predictions of outcome after gonadotropin ovulation induction/intrauterine insemination. Fertil Steril 2014; 101(6): 1649–1655.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×